Company intelligence / Profile preview

Alfa Laval

Ownership: Private
Employees: ~21300
Development stage: Other

Overview

Alfa Laval does not conduct clinical trials or develop drugs; it supplies advanced separation and fluid handling technologies used in biomanufacturing and pharmaceutical production

Industry: Chemicals & Materials

Partnerships

Lonza Biologics – supplier of separators for mammalian cell processing in large-scale biologic manufacturing

Beyond the preview

Go deeper on Alfa Laval.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alfa Laval.

Explore the full profile